Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Research and development

Litigation settlement gain

Restructuring and other charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Align Technology

Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of Invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Scanner and Services segment consists of intraoral scanning systems such as single hardware platforms and restorative or orthodontic software options, ancillary products, and other related additional services. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Align Technology reports Q4 growth, eyes tech advancements for 2023

Align Technology's Q4 performance showed revenue growth in Systems and Services but challenges in Clear Aligner volumes, particularly in China.
The company is focusing on technology advancements, digital subscriptions, and margin improvement for 2023.
Investments in R&D for digital orthodontics and subscription programs present opportunities for future growth.
Despite challenges in China, Align remains optimistic about stability and growth in other regions.

Align Technology beats Q1 revenue expectations, eyes Q2 growth

Align Technology's Q1 performance exceeded expectations with revenue growth.
Stable Clear Aligner business and focus on teen market are strengths.
Challenges include increased expenses and uncertainty in margins.
Opportunities lie in expected volume and ASP increases in Q2.

Align Technology surpasses Q2 expectations, eyes international growth opportunities

Align Technology delivered strong Q2 results, driven by revenue growth in Clear Aligner and Systems and Services segments, with a focus on innovation and strategic initiatives.
The company's performance in international markets, particularly EMEA and APAC, showcased significant growth in teen cases and adoption of the DSP program.
While facing challenges in the teen market and competitive landscape, Align Technology remains optimistic about its long-term growth prospects and market positioning.
Opportunities for Align include continued innovation, market expansion, and investor engagement through strategic initiatives and product differentiation.

Align Technology reports Q3 revenue growth amidst macro challenges

Align Technology navigated challenges in Q3 with revenue growth driven by clear aligner shipments to younger patients and increased services revenue.
Despite lower Q3 demand, the company remains optimistic for 2024 revenue growth through new technologies and digital orthodontics adoption.
Strategic investments in R&D, cost management, and consumer advertising position Align Technology for future growth and margin improvement.

Align Technology surpasses Q4 expectations, eyes innovation for growth

Align Technology delivered strong financial performance in Q4 2023, with robust revenue growth and effective cost management.
The company's focus on innovation, strategic partnerships, and market expansion positions it well for future growth.
While facing challenges such as regulatory approvals and cash flow fluctuations, Align Technology has opportunities in market expansion and cost-saving initiatives.
Overall, Align Technology's performance, strengths, and strategic outlook indicate a positive trajectory for sustainable growth and profitability.

Align Technology posts solid Q1 earnings, eyes growth opportunities

Align Technology's Q1 performance reflects revenue growth and strategic investments in innovation and market expansion.
While facing challenges in operating expenses and margin decline, the company's strengths lie in product innovation and brand visibility.
Opportunities in new market expansion, targeting younger patients, and operational investments set the stage for future growth and profitability.

Align Technology posts solid Q2 results, eyes market expansion

Align Technology delivered strong financial performance in Q2, driven by revenue growth, margin expansion, and increasing adoption of its innovative solutions.
The company's focus on product innovation, digital tools, and marketing initiatives has bolstered its market position and customer engagement.
While facing challenges in a competitive landscape and regulatory processes, Align Technology remains well-positioned to capitalize on opportunities in the orthodontic market.
Strategic initiatives to drive growth, enhance operational efficiency, and expand market reach are key priorities for sustaining momentum and profitability.

Align Technology reports mixed Q3 results, eyes international growth

Align Technology's Q3 '24 showcased mixed results but highlighted growth opportunities in international markets and new product innovations.
Despite challenges in the U.S. market, the company's strategic focus on operational efficiency and digital innovation positions it for future success.
Investments in expansion and supporting doctor customers signal a commitment to driving growth and profitability in the long term.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CONMED

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Conmed (CNMD) or Align Technology (ALGN). But which of these two stocks presents investors with the better value opportunity right now?

CNMD or ALGN: Which Is the Better Value Stock Right Now?

Align Technology missed Wall Street's revenue and earnings estimates for the third quarter. The company also lowered its full-year guidance due in part to economic headwinds.

Why Align Technology Stock Is Crashing Today

Align Technology (NASDAQ:ALGN) Inc shares sank 22% to $197.91 in early Thursday trading after the dental products maker announced third-quarter 2023 financial results that fell short of analysts' estimates on both its top and bottom lines and the company also lowered its full-year forecast for 2023.   Align, which sells products to straighten teeth, reported 3Q adjusted earnings per share (EPS) of $2.14 on revenue that rose 7.8% to $960.2 million.

Align Technology stock drops on 3Q miss; disappointing outlook

Meta's Falling, but This Stock Really Got Kicked in the Teeth Thursday

Align Technology (NASDAQ: ALGN ) stock is falling on Thursday following the release of the Invisalign dental product company's earnings report for the third quarter of 2023. Unfortunately for ALGN stock investors, the company reported adjusted earnings per share of $2.14 during the quarter.

Why Is Align Technology (ALGN) Stock Down 23% Today?

The invisible braces company also misses third-quarter earnings expectations.

Align Technology Stock Falls 24%. It Slashes Guidance as Dental Demand Deteriorates.

Align Technology's (ALGN) Q3 fiscal 2023 performance reflects revenue growth across all regions.

Align Technology (ALGN) Q3 Earnings Miss, Operating Margin Up

Align Technology, Inc. (NASDAQ:ALGN ) Q3 2023 Earnings Conference Call October 25, 2023 4:30 PM ET Company Participants Shirley Stacy - Vice President of Corporate Communications and Investor Relations Joseph Hogan - Director, President and Chief Executive Officer John Morici - Chief Financial Officer and Executive Vice President, Global Finance Conference Call Participants Brandon Vazquez - William Blair Jon Block - Stifel Elizabeth Anderson - Evercore ISI Aaron Wright - Morgan Stanley Nathan Rich - Goldman Sachs Brandon Couillard - Jeffries Mike Ryskin - Bank of America Operator Welcome to Align Technology, Third Quarter 2023 Earnings Call. [Operator Instructions] Please note that this conference call is being recorded.

Align Technology, Inc. (ALGN) Q3 2023 Earnings Call Transcript

Align Technology (ALGN) came out with quarterly earnings of $2.14 per share, missing the Zacks Consensus Estimate of $2.26 per share. This compares to earnings of $1.36 per share a year ago.

Align Technology (ALGN) Lags Q3 Earnings and Revenue Estimates

While the top- and bottom-line numbers for Align Technology (ALGN) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Compared to Estimates, Align Technology (ALGN) Q3 Earnings: A Look at Key Metrics

Invisalign maker Align Technology missed Wall Street's third-quarter expectations late Wednesday, and ALGN stock plummeted to a 10-month low.

Invisalign Maker Align Technology Stock Plunges 23% On Third-Quarter Miss

People are cutting back on dental and orthodontic visits, and that's weighing heavily on shares of Align Technology Inc. in Wednesday's extended session.

Consumers are cutting back on dental visits, and that's hammering this stock

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the third quarter ("Q3'23"). Q3'23 total revenues were $960.2 million, down 4.2% sequentially and up 7.8% year-over-year. Q3'23 Clear Aligner revenues were $794.9 m.

Align Technology Announces Third Quarter 2023 Financial Results

Align Technology (ALGN) third-quarter 2023 results are likely to reflect strength in the Clear Aligner business.

Align Technology (ALGN) to Post Q3 Earnings: What's in Store?

Align Technology (ALGN) has well-established relationships with many DSOs, especially in the United States.

Align (ALGN) Gains From New Launches, Strategic Partnerships

Keurig Dr Pepper Inc

Twilio

Ulta Beauty

Zimmer Biomet Hlds

We have narrowed our search to five large-cap (market capital > $10 billion) stocks with attractive valuations. These stocks are: TWLO, KDP, ULTA, ALGN, ZBH.

5 Large-Cap Stocks to Buy on the Dip for Q4 2023

The heavy selling pressure might have exhausted for Align Technology (ALGN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

After Plunging -11.1% in 4 Weeks, Here's Why the Trend Might Reverse for Align Technology (ALGN)

HubSpot

Netflix

Shopify

Snap

Block

As the curtain fell on September, the stock market lamented its losses. The three major indexes ended last month firmly in the red.

September's Biggest Losers: 7 Popular Stocks That Just Took a Major Hit

Henry Schein

McKesson

West Pharmaceutical Services

Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These include MCK, WST, ALGN and HSIC.

4 Stocks to Buy From the Prospering Dental Supplies Industry

DocuSign

Peloton

Peloton's stock has fallen almost 97% from its all-time high, as losses have piled up. Align Technology's fundamentals remain strong, despite the stock losing 19% last month.

Is It Time to Buy the Nasdaq's Worst-Performing September Stocks?

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report third quarter 2023 financial results on Wednesday, October 25, 2023, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and.

Align Technology to Announce Third Quarter 2023 Results on October 25, 2023

Align Technology, Inc. shares saw a significant pullback in 2022 after a boom in 2021. The company's performance has stabilized, but the current valuation is not appealing. Align is on track to generate $4 billion in sales this year, but earnings power falls short of 2021 levels, and short of levels to see appeal here.

Align Technology: Expectations Run Hot(ter) Again

Here is how Align Technology (ALGN) and Aurinia Pharmaceuticals (AUPH) have performed compared to their sector so far this year.

Are Medical Stocks Lagging Align Technology (ALGN) This Year?

ALGN stock was trading at around $237 in early June 2022, just before the Fed started increasing rates, and is now 26% above that level, compared to 13% gains for the

Will Align Technology (ALGN) Stock Rebound To Its Pre-Inflation Shock Level Of Over $700?

Investors interested in Medical - Dental Supplies stocks are likely familiar with Conmed (CNMD) and Align Technology (ALGN). But which of these two stocks is more attractive to value investors?

News for Align Technology Stock (ALGN)